<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7102556\results\search\testTrace\results.xml">
  <result pre="we focus on advances in research and development of fast" exact="diagnosis" post="methods, as well as potential prophylactics and therapeutics to"/>
  <result pre="this review, we summarize advances made in technologies for rapid" exact="diagnosis" post="and identification of respiratory infections caused by coronavirus, as"/>
  <result pre="of an emerging coronavirus Identification of pathogens mainly includes virus" exact="isolation" post="and viral nucleic acid detection. According to the traditional"/>
  <result pre="nucleic acid detection. According to the traditional Kochâ€™s postulates, virus" exact="isolation" post="is the â€œgold standardâ€� for virus diagnosis in the"/>
  <result pre="Kochâ€™s postulates, virus isolation is the â€œgold standardâ€� for virus" exact="diagnosis" post="in the laboratory. First, viral culture is a prerequisite"/>
  <result pre="or lung tissue, blood and feces) should be retained for" exact="testing" post="in a timely manner, which gives a higher rate"/>
  <result pre="a timely manner, which gives a higher rate of positive" exact="detection" post="of lower respiratory tract specimens. Then, immunological methods â€&quot;"/>
  <result pre="of lower respiratory tract specimens. Then, immunological methods â€&quot; including" exact="immunofluorescence" post="assay, protein microarray, direct fluorescent antibody assay, MAb-based rapid"/>
  <result pre="future [[7], [8], [9]]. All the examples above are traditional" exact="virus detection" post="methods. Viral nucleic acids can also be used for"/>
  <result pre="[[7], [8], [9]]. All the examples above are traditional virus" exact="detection" post="methods. Viral nucleic acids can also be used for"/>
  <result pre="early diagnosis. The following are some of the new coronavirus" exact="detection" post="methods. Polymerase chain reaction (PCR) is a molecular biological"/>
  <result pre="detection methods. Polymerase chain reaction (PCR) is a molecular biological" exact="diagnosis" post="technology based on the sequence of nucleic acids. The"/>
  <result pre="diagnosed by pan-coronavirus PCR for virus identification [11]. Reverse transcription" exact="polymerase chain reaction" post="(RT-PCR) is a technology combining RNA reverse transcription (RT)"/>
  <result pre="patients can be diagnosed by RT-PCR [8]. Reverse transcription-insulated isothermal" exact="polymerase chain reaction" post="(RT-iiPCR), quantitative real-time reverse transcription polymerase chain reaction (qRT-PCR),"/>
  <result pre="[8]. Reverse transcription-insulated isothermal polymerase chain reaction (RT-iiPCR), quantitative real-time" exact="reverse transcription polymerase chain reaction" post="(qRT-PCR), Real-time RT-PCR (rtRT-PCR), and one-step rtRT-PCR were all"/>
  <result pre="transcription-insulated isothermal polymerase chain reaction (RT-iiPCR), quantitative real-time reverse transcription" exact="polymerase chain reaction" post="(qRT-PCR), Real-time RT-PCR (rtRT-PCR), and one-step rtRT-PCR were all"/>
  <result pre="rtRT-PCR was used to identify 2019-nCoV through preliminary and validation" exact="detection" post="of its E gene, RNA-dependent RNA polymerase (RdRp) gene,"/>
  <result pre="(RdRp) gene, and N gene [17]. There are other molecular-based" exact="detection" post="techniques in addition to RT-PCR and similar optimized detection"/>
  <result pre="molecular-based detection techniques in addition to RT-PCR and similar optimized" exact="detection" post="techniques. For example, reverse transcription loop-mediated isothermal amplification (RT-LAMP)"/>
  <result pre="are used to detect the N gene of MERS-CoV, making" exact="detection" post="easier, faster, more efficient and highly specific. Besides these"/>
  <result pre="Peptide Nucleic Acid-induced silver nanoparticles (AgNPs) aggregation of pathogen DNA" exact="testing" post="[24]. The color change of AgNPs can distinguish between"/>
  <result pre="protein has been evaluated in different types of vaccines against" exact="infection" post="by CoVs [29]. Apart from the inactive whole virus"/>
  <result pre="infections [40]. Most CoVs share a similar viral structure, similar" exact="infection" post="pathway, and a similar structure of the S proteins"/>
  <result pre="implying that neutralizing antibodies that were so effective against SARS-CoV" exact="infection" post="may fail to recognize the 2019-nCoV, and that multiple"/>
  <result pre="vaccine could induce neutralizing antibody responses and protection against SARS-CoV" exact="infection" post="in the immunized animals, while it did not elicit"/>
  <result pre="the present, no specific antiviral therapy has been approved for" exact="treatment" post="of infection by human CoVs. As development of vaccines"/>
  <result pre="no specific antiviral therapy has been approved for treatment of" exact="infection" post="by human CoVs. As development of vaccines and compounds"/>
  <result pre="CoVs. As development of vaccines and compounds for prevention and" exact="treatment" post="of infection have been brought to priority status by"/>
  <result pre="development of vaccines and compounds for prevention and treatment of" exact="infection" post="have been brought to priority status by WHO and"/>
  <result pre="bundle (6-HB), blocking S protein-mediated membrane fusion and inhibiting SARS-CoV" exact="infection" post="[59]. When MERS-CoV was circulating in human populations in"/>
  <result pre="the virus HR2 region as well and effectively inhibited MERS-CoV" exact="infection" post="[60]. The further modified version of HR2P, HR2P-M2, presented"/>
  <result pre="noted that many neutralizing antibodies have been successfully discovered for" exact="treatment" post="of SARS-CoV [67] and MERS-CoV infection [45,68,69]. These antibodies"/>
  <result pre="been successfully discovered for treatment of SARS-CoV [67] and MERS-CoV" exact="infection" post="[45,68,69]. These antibodies have all been described favorably in"/>
  <result pre="out from non-immune humans [72,73]. Antibodies effective at inhibiting SARS-CoV" exact="infection" post="should also have the potential for treatment of 2019-nCoV"/>
  <result pre="at inhibiting SARS-CoV infection should also have the potential for" exact="treatment" post="of 2019-nCoV as well, as long as the binding"/>
  <result pre="drug regimens used in patients, numerous drugs developed for the" exact="treatment" post="of infection with CoVs were thoroughly discussed in the"/>
  <result pre="used in patients, numerous drugs developed for the treatment of" exact="infection" post="with CoVs were thoroughly discussed in the literature [57]."/>
  <result pre="hampered by various evaluation methods and animal models used for" exact="testing" post="drug activity among different labs worldwide, which could postpone"/>
  <result pre="CoVs has resulted in multiple strategies for diagnosis, prevention and" exact="treatment" post="of CoV infection. This brief review has demonstrated that"/>
  <result pre="engaged in the development of biologicals have marketed nucleic acid" exact="detection" post="kits for 2019-nCoV, such as the new coronavirus nucleic"/>
  <result pre="kits for 2019-nCoV, such as the new coronavirus nucleic acid" exact="detection" post="kit (double fluorescence PCR method) from Shuoshi Biotechnology. Currently,"/>
  <result pre="Currently, however, no diagnostic test kit is available for the" exact="detection" post="of antibodies to 2019-nCoV. Declaration of Competing Interest The"/>
  <result pre="miracleJÂ Med Virol922020[:???-???] 8WHO: https://www.who.int/docs/default-source/coronaviruse/clinical-management-of-novel-cov.pdf?sfvrsn=bc7da517_2. 9WHO: https://www.who.int/docs/default-source/coronaviruse/20200114-interim-laboratory-guidance-version.pdf?sfvrsn=6967c39b_4&amp;amp;download=true. 10https://www.gisaid.org/. 11http://virological.org/t/initial-assessment-of-the-ability-of-published-coronavirus-primers-sets-to-detect-the-wuhan-coronavirus/321. 12NohJ.Y.YoonS.W.KimD.J.LeeM.S.KimJ.H.NaW.Simultaneous" exact="detection" post="of severe acute respiratory syndrome, Middle East respiratory syndrome,"/>
  <result pre="of two field-deployable reverse transcription-insulated isothermal PCR assays for the" exact="detection" post="of the Middle East respiratory syndrome-coronavirusJÂ Mol Diagn19201781782728807812 14LuX.WhitakerB.SakthivelS.K.KamiliS.RoseL.E.LoweL.Real-time"/>
  <result pre="detecting MERS-CoVFront Microbiol72016216628119682 20HuangP.WangH.CaoZ.JinH.ChiH.ZhaoJ.AÂ rapid and specific assay for the" exact="detection" post="of MERS-CoVFront Microbiol92018110129896174 21Abd El WahedA.PatelP.HeidenreichD.HufertF.T.WeidmannM.Reverse transcription recombinase polymerase"/>
  <result pre="21Abd El WahedA.PatelP.HeidenreichD.HufertF.T.WeidmannM.Reverse transcription recombinase polymerase amplification assay for the" exact="detection" post="of middle East respiratory syndrome coronavirusPLoS Curr52013 22XiuL.ZhangC.WuZ.PengJ.Establishment and"/>
  <result pre="syndrome coronavirusPLoS Curr52013 22XiuL.ZhangC.WuZ.PengJ.Establishment and application of a universal coronavirus" exact="screening" post="method using MALDI-TOF mass spectrometryFront Microbiol82017151028848521 23KooB.HongK.H.JinC.E.KimJ.Y.KimS.H.ShinY.Arch-shaped multiple-target sensing"/>
  <result pre="using MALDI-TOF mass spectrometryFront Microbiol82017151028848521 23KooB.HongK.H.JinC.E.KimJ.Y.KimS.H.ShinY.Arch-shaped multiple-target sensing for rapid" exact="diagnosis" post="and identification of emerging infectious pathogensBiosens Bioelectron1192018798530103157 24TeengamP.SiangprohW.TuantranontA.VilaivanT.ChailapakulO.HenryC.S.Multiplex paper-based"/>
  <result pre="virus variants and individual inÂ vitro escape mutantsJÂ Virol7920059062906815994800 65QiuH.SunS.XiaoH.FengJ.GuoY.TaiW.Single-dose" exact="treatment" post="with a humanized neutralizing antibody affords full protection of"/>
  <result pre="epidemic and zoonotic coronavirusesSci Transl Med92017eaal3653 76GrossA.E.BrysonM.L.Oral ribavirin for the" exact="treatment" post="of noninfluenza respiratory viral infections: a systematic reviewAnn Pharmacother4920151125113526228937"/>
  <result pre="infections: a systematic reviewAnn Pharmacother4920151125113526228937 77ChuC.M.ChengV.C.HungI.F.WongM.M.ChanK.H.ChanK.S.Role of lopinavir/ritonavir in the" exact="treatment" post="of SARS: initial virological and clinical findingsThorax59200425225614985565 78ChanJ.F.ChanK.H.KaoR.Y.ToK.K.ZhengB.J.LiC.P.Broad-spectrum antivirals"/>
 </snippets>
</snippetsTree>
